Exploring the Anti‐Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202301833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Khedidja Benarous und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fundamental sciences laboratory, Amar Telidji University, Laghouat, Algeria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Osteosarcoma, Molecular Docking Simulation, Cell Survival. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Hispidin was initially discovered in basidiomycete Inonotus hispidus (Bull.) P. Karst and this extraordinary compound possesses immense potency and can be extracted from the wild mushroom through specialized bioreactor cultivation techniques. In our study, we isolated it from Inonotus hispidus (Bull.) P. Karst ., with a yield of 3.6 %. We identified and characterized hispidin through the implementation of spectroscopic techniques such as FTIR, NMR, and MS. Additionally, we utilized Thermogravimetric Analysis for thermal characterization of the compound. Computational studies based on DFT were performed to investigate the molecular structure, electronic properties, and chemical reactivity of hispidin. PASS analysis for hispidin demonstrated that 19 of them are anti‐neoplastic activities. The Pharmacology prediction of hispidin confirm that it is not toxic, non‐carcinogenesis with a good human intestinal absorption. The effect of hispidin on the viability of bone cancer cells was evaluated by MTT assay. The results showed that hispidin significantly reduced SaoS2 cell viability in a dose‐dependent manner. Molecular docking was carried out using five targets related to bone cancer to determine the interactions between hispidin and the studied proteins. The results demonstrate that hispidin is a good inhibitor for the five targets. Dynamic simulation shows a good stability of the complex hispidin‐protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundamental sciences laboratory, Amar Telidji University, Laghouat, Algeria.
- Laboratoire de sciences appliquées et didactiques, Ecole Normale Supérieure de, Laghouat, Algeria.
- Department of Biotechnology, University of Health Sciences, İstanbul, Türkiye.
- Experimental Medicine Application and Research Center, Validebag Research Park, University of Health Sciences, İstanbul, Türkiye.
- Department of Biomaterials, University of Health Sciences, İstanbul, Türkiye.
- Chemistry Department, Faculty of Exact Science, University of Constantine 1, Constantine, 25000, Algeria.
Zitieren
APA
Benarous, K., Serseg, T., Mermer, A., Tahmasebifar, A., Boulebd, H., & Linani, A. (2024). Exploring the Anti‐Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301833
Vancouver
Benarous K, Serseg T, Mermer A, Tahmasebifar A, Boulebd H, Linani A. Exploring the Anti‐Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301833
BibTeX
@article{Benarous2024,
author = {Benarous, Khedidja and Serseg, Talia and Mermer, Arif and Tahmasebifar, Aydin and Boulebd, Houssem and Linani, Abderahmane},
title = {Exploring the Anti‐Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202301833}
}
EUVIMED